Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin

Peritoneal Dialysis International

Volumn 20, Issue SUPPL. 5, 2001, Pages

  Lee, J H ^a   Reddy, D K ^a   Saran, R ^a   Moore, H L ^a   Twardowski, Z J ^a   Nolph, K D ^a   Khanna, R ^a  

^a Dongguk University   (South Korea)

Author keywords

Advanced glycosylation end products; Dialysis solutions; Glycosylation; Icodextrin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIANEAL; EXTRANEAL; GLUCOSE; ICODEXTRIN; MONOCLONAL ANTIBODY; PERITONEAL DIALYSIS FLUID; STREPTOZOCIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY WEIGHT; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETERIORATION; DIALYSATE; DRUG INSTILLATION; EQUILIBRIUM DIALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE TRANSPORT; NONHUMAN; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEUM; PLASMA; PRIORITY JOURNAL; RAT; RAT STRAIN; STAINING; STREPTOZOCIN DIABETES; TIME; TISSUE SECTION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035119831     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. CAPD systems and solutions
2. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure
3. Compatibility of peritoneal dialysis fluids containing alternative osmotic agents with cells present in the peritoneal cavity
4. Aspects of new solutions for peritoneal dialysis
5. Categorization of the ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients
6. Kinetics of icodextrin
7. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solution in CAPD
8. Improved ultrafiltration in CCPD patients using icodextrin (I) instead glucose (G) during the long daytime dwell
9. Icodextrin's effects on peritoneal transport
10. Glycation and advanced glycation end-product formation with icodextrin and dextrose
11. Advanced glycosylation end-products
12. Nonenzymatic glycosylation and glucose-dependent cross-linking protein
13. 3-Deoxyfructose concentrations are increased in human plasma and urine in diabetes
14. Increase in 3-deoxyglucosone levels in diabetic rat plasma
15. 2-microglobulin with advanced glycation end-products
16. Pathogenic effects of advanced glycosylation: Biochemical, biologic, clinical implications for diabetes and aging
17. Recent progress on the biologic and clinical significance of advanced glycosylation end-products
18. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
19. Serum advanced glycosylation end-products: A new class of uremic toxins?
20. Non-enzymatic glycosylation and the chronic complications of diabetes. An overview
21. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular diseases
22. Advanced glycosylation end products in peritoneal tissue with different solutions
23. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis
24. Advanced glycation end products in peritoneal dialysis
25. Glycation of albumin with icodextrin
26. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis
27. Microcirculation and diabetes
28. Pathophysiological description of the ultra-structural changes of the peritoneal membrane during long-term continuous ambulatory peritoneal dialysis
29. The effect of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen
30. Laminin alterations after in vitro nonenzymatic glycosylation
31. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties
32. Biocompatibility of peritoneal dialysis fluids
33. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis
34. Abdominal wall thickness as a means of assessing peritoneal fibrosis in mice
35. A previously undescribed side effect of icodextrin: Overestimation of glycemia by glucose analyzer